publication venue for
- Castration-resistant prostate cancer cells are dependent on the high activity of CDK7. 2022
- Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer. 2022
- Protein Kinase C Alpha (PKCĪ±) overexpression leads to a better response to retinoid acid therapy through Retinoic Acid Receptor Beta (RARĪ²) activation in mammary cancer cells.. 146. 2020
- TPP1 OB-fold domain protein suppresses cell proliferation and induces cell apoptosis by inhibiting telomerase recruitment to telomeres in human lung cancer cells.. 145. 2019
- Exploring differences in adverse symptom event grading thresholds between clinicians and patients in the clinical trial setting.. 143. 2017
- BRAF V600E-dependent role of autophagy in uveal melanoma.. 143. 2016
- Relationship between physician-adjudicated adverse events and patient-reported health-related quality of life in a phase II clinical trial (NCT01143402) of patients with metastatic uveal melanoma.. 143. 2016
- Rectal melanoma: epidemiology, prognosis, and role of adjuvant radiation therapy.. 142. 2016
- Exploring an herbal "wonder cure" for cancer: a multidisciplinary approach.. 142. 2016
- Circulating tumor cells in metastatic colorectal cancer: do we need an alternative cutoff?. 139. 2013
- Prognostic value of nuclear matrix protein expression in localized prostate cancer.. 138. 2012
- Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies.. 136. 2009
- A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects.. 135. 2009
- Epidermal growth factor receptor expression analysis in chemotherapy-naive patients with advanced non-small-cell lung cancer treated with gefitinib or placebo in combination with platinum-based chemotherapy.. 135. 2008
- Oncoproteins and proliferation markers in synovial sarcomas: a clinicopathologic study of 19 cases.. 128. 2002
- Basic fibroblast growth factor potentiates cisplatinum-induced cytotoxicity in MCF-7 human breast cancer cells.. 125. 1999
- Phase I/II trial of human recombinant granulocyte-colony-stimulating factor (filgrastim) and escalating doses of cyclophosphamide, mitoxantrone, and 5-FU in the treatment of advanced breast cancer.. 125. 1999
- Diethyldithiocarbamate chemoprotection of carboplatin--induced hematological toxicity.. 119. 1993
- Phase II trial of zeniplatin (CL 286,558), a new patinum compound, in patients with advanced ovarian cancer previously treated with organoplatinum-based therapy.. 119. 1993
- Association between pretreatment CA-125 levels and surgically documented complete responses in patients with ovarian cancer treated with second-line intraperitoneal therapy.. 118. 1992
- Efficacy of cisplatin-based intraperitoneal chemotherapy as treatment of malignant peritoneal mesothelioma.. 118. 1992
- Impact of laparotomy finding of significant intraabdominal adhesions on the surgically defined complete response rate to subsequent salvage intraperitoneal chemotherapy.. 118. 1992
- Phase 2 trial of chronic low-dose oral etoposide as salvage therapy of platinum-refractory ovarian cancer.. 119. 1992
- Salvage intraperitoneal therapy of small-volume residual ovarian cancer: impact of pretreatment finding of peritoneal carcinomatosis on the surgical complete response rate.. 118. 1992
- Persistent hypomagnesemia following cisplatin chemotherapy in patients with ovarian cancer.. 117. 1991
- Phase-1 trial of high-dose intravenous cisplatin with simultaneous intravenous sodium thiosulfate.. 117. 1991
- Primary osteogenic sarcoma: eight-year experience with adjuvant chemotherapy.. 106 Suppl. 1983
- A micromethod for determination of terminal deoxynucleotidyl transferase (TdT) in the diagnostic evaluation of acute leukemias.. 98. 1980
- The role of plant-derived natural substances as immunomodulatory agents in carcinogenesis. 2020
- Implications of flavonoids as potential modulators of cancer neovascularity. 2020
- The role of dietary phytochemicals in the carcinogenesis via the modulation of miRNA expression. 2019
- Controlling metastatic cancer: the role of phytochemicals in cell signaling. 2019
- BDNF and its signaling in cancer. 2022